Humoral tumor B cell–produced IgA responses that sensitize tumor cells to killing by T cells were also described previously (91), and tertiary lymphoid structures, detected in HGSOC tumors, predicted response to immune checkpoint inhibitors (ICIs) (92). Here, CD79A is linked to neoplasm.